Micro biohybrid robots hold potential for drug delivery, say researchers
Researchers have developed a novel microrobot made from bacteria and red blood cells which they say could be an effective form of drug delivery.
List view / Grid view
Researchers have developed a novel microrobot made from bacteria and red blood cells which they say could be an effective form of drug delivery.
Experiments testing the artificial cardiac patch in pigs and rats showed the patch can reduce scarring and improve cardiac function after a heart attack.
A report states that three quarters of the roughly 230 nanopharmaceuticals in clinical development are for use as targeted cancer therapeutics.
Researchers have used triglyceride fatty acids to develop an oral formulation for drugs that are usually injected or taken intravenously.
Researchers have created a microneedle array that successfully delivered a COVID-19 vaccine to mice, allowing them to produce antibodies against the virus.
In an $882 million deal, Evox and Takeda will partner to develop and manufacture treatments and drug delivery systems for rare diseases.
A study comparing the V-Go device administering regular human insulin and rapid acting insulin analogues found they were equally effective and safe at controlling blood glucose.
With the growing trend of injection device use at home, the device optimisation is essential to increase patient safety during self-administration.
Researchers have developed a new device, called a ‘spiral hydroporator’, which uses the power of a tiny fluid vortex to rapidly and efficiently deliver nanomaterials into cells.
A clinical trial has shown that delivery of vaccines via a new high-density microarray patch (HD-MAP) induces a better immune response than needles or syringes.
Developers have announced that they are ready to manufacture and formulate an innovative novel coronavirus vaccine capsule.
Researchers have developed a new rubber-like material that they say has the potential to be used as a form of drug delivery due to its nanopores.
Researchers have created an innovative 3D printing carrier ink to drive the development of personalised biomaterials for cell and drug delivery.
Researchers have shown that using mobile vans to deliver and dispense HIV drugs in South Africa and Uganda helps to combat the disease.
Novel particles could be incorporated into topical creams to treat dermatological conditions without systemic exposure to drugs.